PR

MEZOO, connecting health through technology
Sharing MEZOO’s technology and vision.
External
2026.05.19
MEZOO, ‘HiCardi M350’ Receives MFDS Manufacturing Approval… Begins Launch Process for Next-Generation Product

 

MultiChannel ECG, Arrhythmia Suspicion Signal Detection, and Continuous Temperature Monitoring Supported; Distribution Through Dong-A ST Stepwise Expansion Planned for SpO₂ and Blood Pressure-Related Functions Through Regulatory Approval Procedures



Digital healthcare company MEZOO announced that it has obtained medical device manufacturing approval from the Ministry of Food and Drug Safety for its next-generation wearable patient monitoring device, HiCardi M350, and plans to proceed with the product commercialization process in stages this year.

 

This manufacturing approval marks the first step in the phased commercialization of HiCardi M350. The initially approved functions include ECG, respiration, and continuous temperature monitoring. HiCardi M350 is a wearable patient monitoring device attached to the patient’s chest area, designed to continuously monitor multi-channel ECG signals and heart rate, while also providing arrhythmia suspicion signal detection and continuous temperature monitoring functions. The measured biosignals and device status information support healthcare professionals in monitoring patient conditions.

 

According to MEZOO, the HiCardi product lineup began with a single-channel ECG-based wearable monitoring device and later expanded to HiCardi+, which combined ECG and respiration monitoring, and HiCardi M300, which enhanced multi-channel ECG measurement capabilities. The newly approved HiCardi M350 represents the next stage in this evolution by integrating multi-channel ECG, respiration, and continuous temperature monitoring into a next-generation wearable patient monitoring device.

 

The company stated that this approval is significant because it marks the expansion of MEZOO’s wearable patient monitoring devices from conventional ECG-focused systems to hospital-grade multi-parameter wearable patient monitoring devices combining multi-channel ECG and multiple biosignal monitoring functions. HiCardi M350 is designed to operate for up to 48 hours on a single charge, supporting continuous biosignal monitoring in hospital patient care environments.


 

적용 법률 및 규정
의료기기

하이카디® 시스템은 인허가에 따라 신생아, 소아, 청소년, 18세 이상 환자의 ECG 데이터를 측정하여 부정맥을 진단하는 의료기기로서 의료전문가가 사용하도록 설계되었습니다. 한국 KFDA로부터 의료기기 2등급 인증을 받았습니다. 유럽의료기기 지침(2007/47/EC에 따라 개정된 MDD 93/42/EEC)에 따라 준수된 Class IIb (CE2265). 의료기기 제품으로 CE 승인되었습니다. 미국 FDA는 Class II 510K로 승인 완료 예정입니다.

경고

본 자료는 의료 전문가에게만 배포되며 관련 사진과 함께 제공되는 자료와 관련하여 그 어떤 법적인 책임을 갖지 않습니다. 사용 전 사용 지침서를 주의 깊게 읽으십시오.